Nanobiotix (NBTX) EBIAT (2020 - 2025)

Historic EBIAT for Nanobiotix (NBTX) over the last 6 years, with Q2 2025 value amounting to -$6.1 million.

  • Nanobiotix's EBIAT rose 7413.0% to -$6.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$145.2 million, marking a year-over-year increase of 638.11%. This contributed to the annual value of -$73.7 million for FY2024, which is 7171.56% down from last year.
  • According to the latest figures from Q2 2025, Nanobiotix's EBIAT is -$6.1 million, which was up 7413.0% from -$72.8 million recorded in Q4 2024.
  • Over the past 5 years, Nanobiotix's EBIAT peaked at -$6.1 million during Q2 2025, and registered a low of -$72.8 million during Q4 2024.
  • Moreover, its 5-year median value for EBIAT was -$33.6 million (2021), whereas its average is -$37.3 million.
  • In the last 5 years, Nanobiotix's EBIAT crashed by 7044.56% in 2024 and then soared by 7413.0% in 2025.
  • Over the past 5 years, Nanobiotix's EBIAT (Quarter) stood at -$36.6 million in 2021, then crashed by 58.86% to -$58.2 million in 2022, then grew by 26.6% to -$42.7 million in 2023, then plummeted by 70.45% to -$72.8 million in 2024, then surged by 91.63% to -$6.1 million in 2025.
  • Its EBIAT stands at -$6.1 million for Q2 2025, versus -$72.8 million for Q4 2024 and -$23.6 million for Q2 2024.